ESPL1 and cancer: The results revealed that ESPL1 expression was significantly associated with critical cancer-related pathways including cell cycle (R = 0.33), proliferation (R = 0.31), metastasis (R = 0.31), and DNA damage response (R = 0.31) (Figures 3A–E).